Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jerash Holdings (US) (JRSH) EBIT (2016 - 2025)

Historic EBIT for Jerash Holdings (US) (JRSH) over the last 10 years, with Q4 2025 value amounting to $1.9 million.

  • Jerash Holdings (US)'s EBIT rose 17451.76% to $1.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.4 million, marking a year-over-year increase of 32043.86%. This contributed to the annual value of $1.4 million for FY2025, which is 31758.51% up from last year.
  • Jerash Holdings (US)'s EBIT amounted to $1.9 million in Q4 2025, which was up 17451.76% from $1.1 million recorded in Q3 2025.
  • Over the past 5 years, Jerash Holdings (US)'s EBIT peaked at $5.6 million during Q3 2021, and registered a low of -$3.0 million during Q1 2024.
  • Moreover, its 5-year median value for EBIT was $1.1 million (2023), whereas its average is $1.0 million.
  • Per our database at Business Quant, Jerash Holdings (US)'s EBIT soared by 488595.5% in 2021 and then tumbled by 155489.64% in 2023.
  • Quarter analysis of 5 years shows Jerash Holdings (US)'s EBIT stood at $2.4 million in 2021, then plummeted by 44.86% to $1.3 million in 2022, then crashed by 71.67% to $375799.0 in 2023, then soared by 88.33% to $707727.0 in 2024, then surged by 174.52% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q4 2025, $1.1 million for Q3 2025, and $958996.0 during Q2 2025.